Literature DB >> 1710604

Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha.

P Kontsek1, L Borecký, M Novák, E Kontseková, I Máciková.   

Abstract

Three murine monoclonal antibodies (mAb) directed to distinct epitopes on recombinant human interferon (IFN)-alpha 1, and three mAb recognizing distinct epitopes on recombinant human interferon (IFN) alpha 1, and three mAb recognizing distinct epitopes on recombinant human IFN-alpha sc, were studied by IFN-neutralizing assays. The efficacy of neutralization of the anti-viral and the anti-proliferative activities of IFN-alpha 1, or IFN-alpha 2c, by the specific antibodies used, individually or in combination, were evaluated. In comparison with single mAb, the mixtures of three mAb against IFN-alpha 1 or three mAb against IFN-alpha 2c were capable of neutralizing more than 10-times larger amounts of IFN-alpha 1 and alpha 2c, respectively. The strong potentiation of the neutralization efficacy resulting from mixing different mAb was demonstrated by neutralization of the anti-viral as well as the anti-proliferative activities of both recombinant IFN. The neutralization experiments support the interpretation that the observed potentiation results from simultaneous interaction of anti-IFN mAb with different epitope specificity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710604      PMCID: PMC1384510     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  6 in total

1.  Neutralization of activity of effector protein by monoclonal antibody: formulation of antibody dose-dependence of neutralization for an equilibrium system of antibody, effector, and its cellular receptor.

Authors:  Y Kawade
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  Quantitation of neutralization of interferon by antibody.

Authors:  Y Kawade
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha.

Authors:  P Kontsek; L Borecký; V Lackovic; E Kontseková; Z Sujanová; M Novák
Journal:  Acta Virol       Date:  1989-05       Impact factor: 1.162

4.  Standardization of the chloramine-T method of protein iodination.

Authors:  R Hunter
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

5.  The reaction of the anti-interferon-alpha monoclonal antibody, NK2, with different interferons.

Authors:  J T Whittall; R M King; D C Burke
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

6.  The nature of neutralization reaction between effector protein and monoclonal antibody: a quantitative study of neutralization characteristics of anti-interferon antibodies.

Authors:  Y Kawade; Y Watanabe
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

  6 in total
  1 in total

1.  Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study.

Authors:  Julie Ducreux; Frédéric A Houssiau; Pierre Vandepapelière; Christian Jorgensen; Estibaliz Lazaro; François Spertini; Fabien Colaone; Camille Roucairol; Marion Laborie; Thérèse Croughs; Géraldine Grouard-Vogel; Bernard R Lauwerys
Journal:  Rheumatology (Oxford)       Date:  2016-06-28       Impact factor: 7.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.